Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its ...

The sheer pressure on the pharmaceutical industry to innovate caused a surge of job roles in IT, research and development (R&D), sales, and marketing. R&D in particular enjoyed unprecedented ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Pharmaceutical manufacturing is a key component of Purdue’s One Health initiative, which advances knowledge and innovation related to animal, human and environmental health and well-being through ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) in Q4 CY2024, with sales flat year on year at $594 million. Its ...

The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancements in biotechnology and life sciences research.